NEC Baby Formula Lawsuits To Be Prepared For First Bellwether Trial in May 2025
Judge has given parties involved in NEC baby formula lawsuits until August 2024 to complete fact discovery for the first batch of potential bellwether trials.
Judge has given parties involved in NEC baby formula lawsuits until August 2024 to complete fact discovery for the first batch of potential bellwether trials.
California mother indicates that Enfamil infant formula is "far more dangerous than most prescription drugs" for premature infants, increasing the risk of a devastating gastrointestinal condition.
Hundreds of claims allege Abbott Laboratories or Mead Johnson failed to warn parents and caregivers of the NEC risks from infant formula, but some of the claims fail to identify whether the child received Similac or Enfamil.
Quarterly mediation sessions for the selection of bellwether trials could help lay the groundwork for infant formula NEC lawsuit settlements.
Moderate to late preterm births account for 80% of all preterm births, researchers noted.
Preemies fed infant formula were more than twice as likely to develop necrotizing enterocolitis than those fed donor human milk, researchers found.
Pregnant Black women had double the rate of end-stage kidney disease than their peers, highlighting disparities in treatment, the researchers found.
Report warns that a newborn suffered severe diarrhea and failure to thrive after being exposed to Keytruda in the womb.
Bellwether NEC lawsuit trials will include one complaint against Abbott, one complaint against Mead Johnson, and two complaints that name both infant formula manufacturers as defendants.
Infant probiotics are classified as dietary supplements and not approved by the FDA as a form of medical treatment.